Literature DB >> 16684006

Pathogenesis of haemophilic arthropathy.

G Roosendaal1, F P Lafeber.   

Abstract

The pathogenetic mechanism of haemophilic arthropathy is multifactorial and includes degenerative cartilage-mediated and inflammatory synovium-mediated components. Intra-articular blood first has a direct effect on cartilage, as a result of the iron-catalysed formation of destructive oxygen metabolites (resulting in chondrocyte apoptosis), and subsequently affects the synovium, in addition to haemosiderin-induced synovial triggering. Both processes occur in parallel, and while they influence each other they probably do not depend on each other. This concept resembles degenerative joint damage as found in osteoarthritis as well as inflammatory processes in rheumatoid arthritis. These processes finally result in a fibrotic and destroyed joint.

Entities:  

Mesh:

Year:  2006        PMID: 16684006     DOI: 10.1111/j.1365-2516.2006.01268.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN: 1351-8216            Impact factor:   4.287


  45 in total

1.  Rationale for a randomized controlled trial comparing two prophylaxis regimens in adults with severe hemophilia A: the Hemophilia Adult Prophylaxis Trial.

Authors:  Margaret V Ragni
Journal:  Expert Rev Hematol       Date:  2011-10       Impact factor: 2.929

Review 2.  New and Emerging Agents for the Treatment of Hemophilia: Focus on Extended Half-Life Recombinant Clotting Proteins.

Authors:  Margaret V Ragni
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 3.  Secondary prophylaxis in adolescent and adult haemophiliacs.

Authors:  Annarita Tagliaferri; Caterina Di Perna; Gianna Franca Rivolta
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

Review 4.  Clinical use of factor VIII and factor IX concentrates.

Authors:  Massimo Morfini; Antonio Coppola; Massimo Franchini; Giovanni Di Minno
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

5.  Joint scores in hemophilic arthropathy in children: Developing country perspectives.

Authors:  Aritra Guha; Akash Rai; Arnab Nandy; Tanushree Mondal; Narayan Pandit; Sumantra Guha; Dipankar Gupta; Rakesh Mondal
Journal:  Eur J Rheumatol       Date:  2019-12-16

6.  The importance of genetic factors for the development of arthropathy: a longitudinal study of children and adolescents with haemophilia A.

Authors:  Edward D Gomperts; John Schwarz; Sharyne M Donfield; Alice E Lail; Jan Astermark; W Keith Hoots; Cheryl A Winkler; Erik Berntorp
Journal:  Thromb Haemost       Date:  2016-12-08       Impact factor: 5.249

7.  Quantitative versus semiquantitative MR imaging of cartilage in blood-induced arthritic ankles: preliminary findings.

Authors:  Andrea S Doria; Ningning Zhang; Bjorn Lundin; Pamela Hilliard; Carina Man; Ruth Weiss; Gary Detzler; Victor Blanchette; Rahim Moineddin; Felix Eckstein; Marshall S Sussman
Journal:  Pediatr Radiol       Date:  2014-02-13

8.  Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.

Authors:  Shannon M Zintner; Juliana C Small; Giulia Pavani; Lynn Dankner; Oscar A Marcos-Contreras; Phyllis A Gimotty; Mads Kjelgaard-Hansen; Bo Wiinberg; Paris Margaritis
Journal:  Blood Adv       Date:  2019-02-12

9.  Pilot randomized, non-inferiority, cross-over trial of once-weekly vs. three times-weekly recombinant factor VIII prophylaxis in adults with severe haemophilia A.

Authors:  M V Ragni; J G Yabes; P F Fogarty; N C Josephson; C M Kessler; A T Neff; L Raffini; K Brummel-Ziedins; C G Moore
Journal:  Haemophilia       Date:  2016-12-11       Impact factor: 4.287

10.  Clinical, instrumental, serological and histological findings suggest that hemophilia B may be less severe than hemophilia A.

Authors:  Daniela Melchiorre; Silvia Linari; Mirko Manetti; Eloisa Romano; Francesco Sofi; Marco Matucci-Cerinic; Christian Carulli; Massimo Innocenti; Lidia Ibba-Manneschi; Giancarlo Castaman
Journal:  Haematologica       Date:  2015-10-22       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.